Michael S Brown Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

Michael S Brown is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 1,548 shares of REGN, which is worth approximately $1.1 Million. The most recent transaction as insider was on Sep 13, 2021, when has been sold 9,704 shares (Common Stock) at a price of $402.54 per share, resulting in proceeds of $3,906,248. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.55K

12.01% 3M change

12.01% 12M change

Total Value Held $1.1 Million

MICHAEL S BROWN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 13 2021	BUY Exercise of conversion of derivative security	$3,906,248 $402.54 p/Share	9,704 Added 47.81%	10,595 Common Stock
Jun 25 2021	SELL Open market or private sale	$1,144,116 $549.0 p/Share	2,084 Reduced 70.05%	891 Common Stock
Jun 25 2021	BUY Exercise of conversion of derivative security	$773,998 $371.4 p/Share	2,084 Added 41.19%	2,975 Common Stock
Jun 14 2021	SELL Open market or private sale	$892,500 $525.0 p/Share	1,700 Reduced 65.61%	891 Common Stock
Jun 14 2021	BUY Exercise of conversion of derivative security	$631,380 $371.4 p/Share	1,700 Added 39.62%	2,591 Common Stock
Jan 25 2021	SELL Open market or private sale	$1,374,714 $554.32 p/Share	2,480 Reduced 73.57%	891 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$944,756 $380.95 p/Share	2,480 Added 42.39%	3,371 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	248 Added 21.77%	891 Common Stock
Sep 22 2020	SELL Open market or private sale	$2,811,512 $552.36 p/Share	5,090 Reduced 88.78%	643 Common Stock
Sep 22 2020	BUY Exercise of conversion of derivative security	$1,928,193 $378.82 p/Share	5,090 Added 47.03%	5,733 Common Stock
Jul 01 2020	SELL Open market or private sale	$2,207,651 $611.03 p/Share	3,613 Reduced 84.89%	643 Common Stock
Jul 01 2020	BUY Exercise of conversion of derivative security	$1,493,361 $413.33 p/Share	3,613 Added 45.91%	4,256 Common Stock
May 07 2020	SELL Open market or private sale	$1,016,658 $562.0 p/Share	1,809 Reduced 73.78%	643 Common Stock
May 06 2020	SELL Payment of exercise price or tax liability	$2,034,673 $555.77 p/Share	3,661 Reduced 59.89%	2,452 Common Stock
May 06 2020	BUY Exercise of conversion of derivative security	$1,778,734 $325.18 p/Share	5,470 Added 67.99%	2,575 Common Stock
Feb 24 2020	SELL Open market or private sale	$838,020 $419.01 p/Share	2,000 Reduced 75.67%	643 Common Stock
Feb 24 2020	BUY Exercise of conversion of derivative security	$547,340 $273.67 p/Share	2,000 Added 43.08%	2,643 Common Stock

MSB

Michael S Brown

Director

Tarrytown, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Value

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN

Account